loading page

Expression of circulating angiotensin-converting enzyme 2 in children with asthma and the effects of inhaled corticosteroids -- ACE2 expression in children with asthma
  • +7
  • xiang ma,
  • Lesen Liu,
  • jing sun,
  • yun zhang,
  • yanqin liu,
  • miao liu,
  • Bing Wang,
  • Yuna Chang,
  • yuling han,
  • Zhongtao Gai
xiang ma
Shandong University
Author Profile
Lesen Liu
Shandong University
Author Profile
jing sun
Shandong University
Author Profile
yun zhang
Shandong University
Author Profile
yanqin liu
Shandong University
Author Profile
miao liu
Shandong University
Author Profile
Bing Wang
Shandong University
Author Profile
Yuna Chang
Shandong University
Author Profile
yuling han
Shandong University
Author Profile
Zhongtao Gai
Shandong University

Corresponding Author:[email protected]

Author Profile

Abstract

Background: The global spread of Corona Virus Disease 2019 (COVID-19) has resulted in a significant disease burden, yet asthma patients do not have the expected high morbidity and mortality rates in the pandemics of COVID-19. Objective:To find the difference of angiotensin-converting enzyme 2 (ACE2) in asthma and non-asthma children and evaluate the effect of inhaled corticosteroids (ICS) on its expression. Methods: The ACE2, immunoglobulin E (IgE) and eosinophils were tested in different children. Results: A total of 157 children aged 3-16 years were enrolled. The expression of ACE2 in asthma children were lower than non-asthma children (T=-2.512, P=0.013). Allergic non-asthma children had a significant higher ACE2 expression than children with allergic asthma (P=0.013) and non-allergic asthma (P=0.029). The expression of ACE2 had no significant difference between first diagnosed asthma children and that had been treated with ICS for≥6 months (F=0.028, P=0.598). The allergic asthma children showed a significantly higher Eosinophils cells (EC) count than the allergic non-asthma (W=200, P<0.001) and non-allergic non-asthma children (W=1089, P<0.001). Non-allergic asthma children also had a significant higher EC count than the allergic non-asthma (W=182.5, P<0.001) and non-allergic non-asthma (W= 200.5, P<0.001) children. There was no significant difference in IgE levels between asthmatic children and non-asthmatic children (W=2792.5, P= 0.18). Conclusion: Circulating ACE2 levels in asthmatic children were lower than those in non-asthmatic children and ICS treatment for ≥6 months did not affect the expression of ACE2 in peripheral blood in the asthma children.